FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225526177> ?p ?o ?g. }

• W4225526177 endingPage "2344" @default.
• W4225526177 startingPage "2328" @default.
• W4225526177 abstract "Hyperbranched polymers have many promising features for drug delivery, owing to their ease of synthesis, multiple functional group content, and potential for high drug loading with retention of solubility. Here we prepared hyperbranched N-(2-hydroxypropyl)methacrylamide (HPMA) polymers with a range of molar masses and particle sizes, and with attached dyes, radiolabel or the anticancer drug gemcitabine. Reversible addition-fragmentation chain transfer (RAFT) polymerisation enabled the synthesis of pHPMA polymers and a gemcitabine-comonomer functionalised pHPMA polymer pro-drug, with diameters of the polymer particles ranging from 7-40 nm. The non-drug loaded polymers were well-tolerated in cancer cell lines and macrophages, and were rapidly internalised in 2D cell culture and transported efficiently to the centre of dense pancreatic cancer 3D spheroids. The gemcitabine-loaded polymer pro-drug was found to be toxic both to 2D cultures of MIA PaCa-2 cells and also in reducing the volume of MIA PaCa-2 spheroids. The non-drug loaded polymers caused no short-term adverse effects in healthy mice following systemic injection, and derivatives of these polymers labelled with 89Zr-were tracked for their distribution in the organs of healthy and MIA PaCa-2 xenograft bearing Balb/c nude mice. Tumour accumulation, although variable across the samples, was highest in individual animals for the pHPMA polymer of ∼20 nm size, and accordingly a gemcitabine pHPMA polymer pro-drug of ∼18 nm diameter was evaluated for efficacy in the tumour-bearing animals. The efficacy of the pHPMA polymer pro-drug was very similar to that of free gemcitabine in terms of tumour growth retardation, and although there was a survival benefit after 70 days for the polymer pro-drug, there was no difference at day 80. These data suggest that while polymer pro-drugs of this type can be effective, better tumour targeting and enhanced in situ release remain as key obstacles to clinical translation even for relatively simple polymers such as pHPMA." @default.
• W4225526177 created "2022-05-05" @default.
• W4225526177 creator A5010338523 @default.
• W4225526177 creator A5010793898 @default.
• W4225526177 creator A5014665196 @default.
• W4225526177 creator A5017530405 @default.
• W4225526177 creator A5027280548 @default.
• W4225526177 creator A5033723598 @default.
• W4225526177 creator A5034302686 @default.
• W4225526177 creator A5045933245 @default.
• W4225526177 creator A5049455451 @default.
• W4225526177 creator A5056060581 @default.
• W4225526177 creator A5061346222 @default.
• W4225526177 creator A5062728145 @default.
• W4225526177 creator A5076407919 @default.
• W4225526177 creator A5081645339 @default.
• W4225526177 creator A5091194683 @default.
• W4225526177 date "2022-01-01" @default.
• W4225526177 modified "2023-10-14" @default.
• W4225526177 title "Synthesis, characterisation and evaluation of hyperbranched <i>N</i>-(2-hydroxypropyl) methacrylamides for transport and delivery in pancreatic cell lines <i>in vitro</i> and <i>in vivo</i>" @default.
• W4225526177 cites W1636022800 @default.
• W4225526177 cites W1819045417 @default.
• W4225526177 cites W1932279399 @default.
• W4225526177 cites W1946895920 @default.
• W4225526177 cites W1965593909 @default.
• W4225526177 cites W1968165703 @default.
• W4225526177 cites W1988298305 @default.
• W4225526177 cites W1999964689 @default.
• W4225526177 cites W2003336829 @default.
• W4225526177 cites W2008410018 @default.
• W4225526177 cites W2018672565 @default.
• W4225526177 cites W2019859798 @default.
• W4225526177 cites W2024315050 @default.
• W4225526177 cites W2026094490 @default.
• W4225526177 cites W2028015042 @default.
• W4225526177 cites W2030086541 @default.
• W4225526177 cites W2033999645 @default.
• W4225526177 cites W2038026193 @default.
• W4225526177 cites W2038882972 @default.
• W4225526177 cites W2046575243 @default.
• W4225526177 cites W2047412840 @default.
• W4225526177 cites W2057591525 @default.
• W4225526177 cites W2058901868 @default.
• W4225526177 cites W2064653722 @default.
• W4225526177 cites W2072198924 @default.
• W4225526177 cites W2080544115 @default.
• W4225526177 cites W2083710155 @default.
• W4225526177 cites W2087485526 @default.
• W4225526177 cites W2092880308 @default.
• W4225526177 cites W2093959324 @default.
• W4225526177 cites W2094364086 @default.
• W4225526177 cites W2098378066 @default.
• W4225526177 cites W2130251950 @default.
• W4225526177 cites W2140857512 @default.
• W4225526177 cites W2143737548 @default.
• W4225526177 cites W2151477149 @default.
• W4225526177 cites W218869826 @default.
• W4225526177 cites W2287333506 @default.
• W4225526177 cites W2296303651 @default.
• W4225526177 cites W2312341861 @default.
• W4225526177 cites W2317606986 @default.
• W4225526177 cites W2397541390 @default.
• W4225526177 cites W2496863683 @default.
• W4225526177 cites W2528719437 @default.
• W4225526177 cites W2601442454 @default.
• W4225526177 cites W2609219422 @default.
• W4225526177 cites W2727683504 @default.
• W4225526177 cites W2733141700 @default.
• W4225526177 cites W2738695540 @default.
• W4225526177 cites W2740395248 @default.
• W4225526177 cites W2744259335 @default.
• W4225526177 cites W2765748477 @default.
• W4225526177 cites W2774901009 @default.
• W4225526177 cites W2787089391 @default.
• W4225526177 cites W2793093272 @default.
• W4225526177 cites W2805521463 @default.
• W4225526177 cites W2889623068 @default.
• W4225526177 cites W2892219553 @default.
• W4225526177 cites W2899132714 @default.
• W4225526177 cites W2900482885 @default.
• W4225526177 cites W2904389476 @default.
• W4225526177 cites W2910268222 @default.
• W4225526177 cites W2945326498 @default.
• W4225526177 cites W3092833851 @default.
• W4225526177 doi "https://doi.org/10.1039/d1bm01548f" @default.
• W4225526177 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35380131" @default.
• W4225526177 hasPublicationYear "2022" @default.
• W4225526177 type Work @default.
• W4225526177 citedByCount "3" @default.
• W4225526177 countsByYear W42255261772022 @default.
• W4225526177 countsByYear W42255261772023 @default.
• W4225526177 crossrefType "journal-article" @default.
• W4225526177 hasAuthorship W4225526177A5010338523 @default.
• W4225526177 hasAuthorship W4225526177A5010793898 @default.
• W4225526177 hasAuthorship W4225526177A5014665196 @default.
• W4225526177 hasAuthorship W4225526177A5017530405 @default.
• W4225526177 hasAuthorship W4225526177A5027280548 @default.
• W4225526177 hasAuthorship W4225526177A5033723598 @default.

• next